Carregant...
Cytomegalovirus vaccine: phase II clinical trial results
Cytomegalovirus (CMV) is one of the most significant viral pathogens during pregnancy and in immunocompromised patients. Antiviral prophylactic strategies are limited by toxicities, drug–drug interactions and development of antiviral resistance. A safe and protective vaccine against CMV is highly de...
Guardat en:
| Publicat a: | Clin Microbiol Infect |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5716458/ https://ncbi.nlm.nih.gov/pubmed/24283990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1469-0691.12449 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|